Abstract:The pioneer transcription factor GATA4 is expressed in multiple cardiovascular lineages and is essential for heart development. GATA4 lineage-specific occupancy in the developing heart underlies its lineage specific activities. Here, we characterized GATA4 chromatin occupancy in cardiomyocyte and endocardial lineages, dissected mechanisms that control lineage specific occupancy, and analyzed GATA4 regulation of endocardial gene expression. We mapped GATA4 chromatin occupancy in cardiomyocyte and endocardial cells of embryonic day 12.5 (E12.5) mouse heart using lineage specific, Cre-activated biotinylation of GATA4. Regulation of GATA4 pioneering activity was studied in cell lines stably overexpressing GATA4. GATA4 regulation of endocardial gene expression was analyzed using single cell RNA sequencing and luciferase reporter assays. Cardiomyocyte-selective and endothelial-selective GATA4 occupied genomic regions had features of lineage specific enhancers. Footprints within cardiomyocyte- and endothelial-selective GATA4 regions were enriched for NKX2-5 and ETS1 motifs, respectively, and both of these TFs interacted with GATA4 in co-immunoprecipitation assays. In stable NIH3T3 cell lines expressing GATA4 with or without NKX2-5 or ETS1, the partner TFs re-directed GATA4 pioneer binding and augmented its ability to open previously inaccessible regions, with ETS1 displaying greater potency as a pioneer partner than NKX2-5. Single-cell RNA sequencing of embryonic hearts with endothelial cell–specific Gata4 inactivation identified Gata4 -regulated endocardial genes, which were adjacent to GATA4-bound, endothelial regions enriched for both GATA4 and ETS1 motifs. In reporter assays, GATA4 and ETS1 cooperatively stimulated endothelial cell enhancer activity. Lineage selective non-pioneer TFs NKX2-5 and ETS1 guide the activity of pioneer TF (transcription factor) GATA4 to bind and open chromatin and create active enhancers and mechanistically link ETS1 interaction to GATA4 regulation of endocardial development. Download figure Download PowerPoint

GATA4 Regulates ANF Expression Synergistically with Sp1 in a Cardiac Hypertrophy Model

DEC1 represses cardiomyocyte hypertrophy by recruiting PRP19 as an E3 ligase to promote ubiquitination-proteasome-mediated degradation of GATA4

GRP78 (Glucose-Regulated Protein of 78 Kda) Promotes Cardiomyocyte Growth Through Activation of GATA4 (Gata-Binding Protein 4)

Transcriptional Control Of Pacemaker Channel Genes Hcn2 And Hcn4 By Sp1 And Implications In Re-Expression Of These Genes In Hypertrophied Myocytes

[Role of GATA-4 in Cardiac Development and Remodeling].

Possible Mechanism of GATA4 Inhibiting Myocardin Activity During Cardiac Hypertrophy

Sp1-induced LncRNA CTBP1-AS2 is a Novel Regulator in Cardiomyocyte Hypertrophy by Interacting with FUS to Stabilize TLR4

Relationship between HSPA1A-regulated gene expression and alternative splicing in mouse cardiomyocytes and cardiac hypertrophy

Involvement of ERK–RSK Cascade in Phenylephrine-Induced Phosphorylation of GATA4

TIEG1 Inhibits Angiotensin II–induced Cardiomyocyte Hypertrophy by Inhibiting Transcription Factor GATA4

Mitogen-activated protein kinases ERK 1/2-and p38-GATA-4 pathways mediate the Ang II-induced activation of FGF-2 gene in neonatal rat cardiomyocytes

Beta-Catenin/tcf/lef1 Can Directly Regulate Phenylephrine-Induced Cell Hypertrophy and Anf Transcription in Cardiomyocytes.

Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, And Fibrosis Induced By Pressure Overload

TRAF Family Member 4 Promotes Cardiac Hypertrophy Through the Activation of the AKT Pathway

GATA4 Regulates Developing Endocardium Through Interaction With ETS1

Interaction of cardiac transcription factor Nkx2.5 and GATA4

Dynamic GATA4 Enhancers Shape the Chromatin Landscape Central to Heart Development and Disease.

The Role of Angiopoietin-like Protein 4 in Phenylephrine-induced Cardiomyocyte Hypertrophy.

NFATc4 and Myocardin Synergistically Up-Regulate the Expression of LTCC Α1c in ET-1-induced Cardiomyocyte Hypertrophy.

Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway

PS-B02-1: UPREGULATION OF KEY GENES ELN AND TGFB3 WERE ASSOCIATED WITH THE SEVERITY OF CARDIAC HYPERTROPHY